CX 2025: Bioresorbable scaffold technology has ‘potential to be a new paradigm for femoropopliteal endovascular intervention’ – Vascular News

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.